Clinical Trial Update: Phase 2a ID93 + GLA-SE Vaccine Trial in TB Patients After Treatment Completion [Phase 2]

View source ↗

Summary

Phase 2a trial of ID93 + GLA-SE vaccine in adults with pulmonary tuberculosis completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• ID93 + GLA-SE vaccine

Snippet

Sponsor: Access to Advanced Health Institute (AAHI) | Conditions: Pulmonary Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2018-11-09